Evidence map›Paper›PMID 37305441›Full record

ArticleJHEP reports : innovation in hepatology2023

Expanding epidemic of recently acquired HCV in HIV-coinfected patients over a period of 10 years.

Christiana Graf, Lara Fuhrmann, Thomas Lutz, Christoph Stephan, Gaby Knecht, Peter Gute, Markus Bickel, Kai-Henrik Peiffer, Fabian Finkelmeier, Georg Dultz and 8 more

Open access · goldAbstract read
In one paragraph

Article in JHEP reports : innovation in hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 2 countries.

Christiana GrafDepartment of Internal Medicine 1, University Hospital, Goethe University, Frankfurt, Germany.
Lara FuhrmannDepartment of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
Thomas LutzInfektiologikum, Frankfurt, Germany.
Christoph StephanHIVCENTER, Department of Infectious Diseases, University Hospital, Goethe University, Frankfurt, Germany.
Gaby KnechtInfektiologikum, Frankfurt, Germany.
Peter GuteInfektiologikum, Frankfurt, Germany.
Markus BickelInfektiologikum, Frankfurt, Germany.
Kai-Henrik PeifferDepartment of Internal Medicine 1, University Hospital, Goethe University, Frankfurt, Germany.
Fabian FinkelmeierDepartment of Internal Medicine 1, University Hospital, Goethe University, Frankfurt, Germany.
Georg DultzDepartment of Internal Medicine 1, University Hospital, Goethe University, Frankfurt, Germany.
Antonia MondorfDepartment of Internal Medicine 1, University Hospital, Goethe University, Frankfurt, Germany.
Nils WetzsteinHIVCENTER, Department of Infectious Diseases, University Hospital, Goethe University, Frankfurt, Germany.
Natalie FilmannInstitute of Biostatistics and Mathematical Modeling, Goethe University, Frankfurt, Germany.
Eva HerrmannInstitute of Biostatistics and Mathematical Modeling, Goethe University, Frankfurt, Germany.
Stefan ZeuzemDepartment of Internal Medicine 1, University Hospital, Goethe University, Frankfurt, Germany.
Niko BeerenwinkelDepartment of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
Julia DietzDepartment of Internal Medicine 1, University Hospital, Goethe University, Frankfurt, Germany.
Christoph SarrazinDepartment of Internal Medicine 1, University Hospital, Goethe University, Frankfurt, Germany.
Goethe University Frankfurt · DESIB Swiss Institute of Bioinformatics · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & Aims: Ongoing transmission of HCV infections is associated with risk factors such as drug injection, needlestick injuries, and men who have sex with men (MSM). Ways of transmission, the course of acute infection, changes of virologic features, and incidence over time are not well known. Methods: Over a period of 10 years, n = 161 patients with recently acquired HCV infection (RAHC) (median follow-up 6.8 years) were prospectively enrolled. NS5B sequencing was performed to re-evaluate the HCV genotype (GT) and for phylogenetic analyses. Results: Patients with RAHC were mainly male (92.5%), MSM (90.1%), and HIV-coinfected (86.3%). Transmission risk factors for MSM and non-MSM were sexual risk behaviour (100 and 6.3%, respectively), injection drug use (9.7 and 37.5%, respectively), and nasal drug use (15.2 and 0%, respectively). Spontaneous and interferon- or direct-acting antiviral-based clearance rates were 13.6, 84.3 and 93.4%, respectively. Mean RAHC declined from 19.8 in the first to 13.2 in the past five study years. Although the majority of infections was caused by HCV GT1a, the frequency of HCV GT4d and slightly HCV GT3a increased over time. No relevant clustering of HCV isolates was observed in non-MSM. However, 45% of HCV GT1a and 100% of HCV GT4d MSM cases clustered with MSM isolates from other countries. Travel-associated infections were supported by personal data in an MSM subgroup. No international clustering was detected in MSM with HCV GT1b or HCV GT3a. Conclusions: RAHCs were mainly diagnosed in HIV-coinfected MSM patients and were associated with sexual risk behaviour. Spontaneous clearance rates were low, and phylogenetic clusters were observed in the majority of patients. Impact and Implications: We evaluated the occurrence and transmission of recently acquired HCV infections (RAHCs) over a period of 10 years. Our data demonstrate that the presence of RAHC was mainly found in HIV-coinfected MSM, with internationally connected transmission networks being observed in the majority of patients. Spontaneous clearance rates were low, and reinfection rates increased mainly driven by a small subset of MSM patients with high-risk behaviour.

Indexed as

Acute HCV infectionHCVHIV coinfectionMSMNS5B phylogeny

Identifiers

PMID37305441
PMCPMC10250927
OpenAlexW4321378566

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.